Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4677 results

Sort By:

Evaluation of Dental Caries Using Caries Assessment Spectrum and Treatment Need (CAST) Index, International Caries Detection and Assessment System (ICDAS) Index and World Health Organization (WHO) Index

Study ID: NCT06858462
Start Date: 2025-05
End Date: 2025-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

Immunity With Acute Hepatits A

Study ID: NCT06942962
Start Date: 2025-10-01
End Date: 2026-11-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

Study ID: NCT06840691
Start Date: 2025-05
End Date: 2025-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

87

Intervention / Treatment

PEG-rhGH with new preparation (T)

PEG-rhGH with present preparation (T)

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Prevalence of Tooth Wear and Its Association with Oral Health-related Quality of Life

Study ID: NCT06665191
Start Date: 2026-02
End Date: 2026-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1011

Intervention / Treatment

No Intervention: Observational study for prevalence of dental wear and its association with quality of life

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Study ID: NCT06876662
Start Date: 2025-05
End Date: 2032-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

279

Intervention / Treatment

Pester

Sponsor

Eli Lilly and Company

Source: clinicaltrials.gov

Share:
Add to list

CongenItal Naevus Cohort for Longitudinal Evaluation

Study ID: NCT06828822
Start Date: 2025-06-01
End Date: 2031-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

819

Intervention / Treatment

Neurodevelopmental assessment

Meeting with the parents

Patient quality of life assessment

Sponsor

Nantes University Hospital

Source: clinicaltrials.gov

Share:
Add to list

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

Study ID: NCT06204991
Start Date: 2025-05-01
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

ADP-TILIL7

Cyclophosphamide

Fludarabine Phosphate

Pre -bine

Sponsor

Inge Marie Svane

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Text-messaging on Activity Limitation in People With Chronic Low Back

Study ID: NCT06903091
Start Date: 2025-06-01
End Date: 2027-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

SMS

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer

Study ID: NCT06954480
Start Date: 2025-08
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

140

Intervention / Treatment

Datopotamab Deruxtecan (Dato-DXd)

Durvalumab

Sponsor

Queen Mary University of London

Source: clinicaltrials.gov

Share:
Add to list

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

Study ID: NCT06938880
Start Date: 2025-05
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

ZGGS18 for Injection

ZG005 for Injection

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Source: clinicaltrials.gov

Share:
Add to list